Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the …

RG Dos Santos, FL Osório, JAS Crippa… - Therapeutic …, 2016 - journals.sagepub.com
To date, pharmacological treatments for mood and anxiety disorders and for drug dependence
show limited efficacy, leaving a large number of patients suffering severe and persistent …

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic …

RG Dos Santos, JC Bouso… - Expert review of …, 2018 - Taylor & Francis
Introduction: Mood, anxiety, and substance-use disorders are among the most prevalent
psychiatric disorders in the population. Although several pharmacological treatments are …

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

RG Dos Santos, JC Bouso… - Therapeutic advances in …, 2017 - journals.sagepub.com
Ayahuasca is a hallucinogen brew traditionally used for ritual and therapeutic purposes in
Northwestern Amazon. It is rich in the tryptamine hallucinogens dimethyltryptamine (DMT), …

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

…, FL Osório, R Sanches, RG Dos Santos… - Psychological …, 2019 - cambridge.org
BackgroundRecent open-label trials show that psychedelics, such as ayahuasca, hold
promise as fast-onset antidepressants in treatment-resistant depression.MethodsTo test the …

[HTML][HTML] Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

…, RF Sanches, LR Macedo, RG Dos Santos… - Brazilian Journal of …, 2015 - SciELO Brasil
dos Santos RG. Safety and side effects of ayahuasca in humans - An overview focusing on
dos Santos RG. Safety and side effects of ayahuasca in humans - An overview focusing on …

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study

…, F de Lima Osório, RG Dos Santos… - Journal of clinical …, 2016 - journals.lww.com
Ayahuasca is an Amazonian botanical hallucinogenic brew which contains dimethyltryptamine,
a 5-HT 2A receptor agonist, and harmine, a monoamine-oxidase A inhibitor. Our group …

Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM‐5–Clinician Version (SCID‐5‐CV)

…, RG Dos Santos, R Martin‐Santos… - Psychiatry and …, 2019 - Wiley Online Library
Aim The Structured Clinical Interview for the DSM is one of the most used diagnostic
instruments in clinical research worldwide. The current Clinician Version of the instrument (SCID‐5‐…

[HTML][HTML] Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

RG Dos Santos, FL Osório, JAS Crippa… - Brazilian Journal of …, 2016 - SciELO Brasil
… Labate BC, Rose IS, dos Santos RG. Ayahuasca religions: a comprehensive bibliography
dos Santos RG. Safety and side effects of ayahuasca in humans -- an overview focusing on …

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine

RG Dos Santos, M Valle, JC Bouso… - Journal of clinical …, 2011 - journals.lww.com
Ayahuasca is an Amazonian psychotropic plant tea combining the 5-HT 2A agonist N, N-dimethyltryptamine
(DMT) and monoamine oxidase-inhibiting β-carboline alkaloids that render …

Pharmacology of ayahuasca administered in two repeated doses

RG Dos Santos, E Grasa, M Valle, MR Ballester… - …, 2012 - Springer
Rationale Ayahuasca is an Amazonian tea containing the natural psychedelic 5-HT 2A/2C/1A
agonist N,N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its visionary …